Orphazyme co-founder becomes board chair at biotech startup
![Anders Hinsby, CEO of Muna Therapeutics and chairman of the board at Pephexia Therapeutics. | Photo: Muna Therapeutics / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14222274.ece/ALTERNATES/schema-16_9/doc7lrcc412dlh85elik3i.jpg)
In 2019, Anders Hinsby left his role as CEO of Orphazyme, a company he helped to establish back in 2010.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Orphazyme CEO on sale: "It’s sad, but we tried everything"
For subscribers
Former Bioporto CEO to lead board of medtech firm
For subscribers